SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-041801
Filing Date
2019-11-07
Accepted
2019-11-07 16:28:17
Documents
52
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q arav-10q_20190930.htm 10-Q 1403086
2 EX-31.1 arav-ex311_12.htm EX-31.1 17183
3 EX-31.2 arav-ex312_10.htm EX-31.2 17178
4 EX-32.1 arav-ex321_11.htm EX-32.1 7632
5 EX-32.2 arav-ex322_9.htm EX-32.2 7682
  Complete submission text file 0001564590-19-041801.txt   4874175

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT arav-20190930.xml EX-101.INS 970140
7 XBRL TAXONOMY EXTENSION SCHEMA arav-20190930.xsd EX-101.SCH 36546
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arav-20190930_cal.xml EX-101.CAL 39541
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arav-20190930_def.xml EX-101.DEF 94890
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE arav-20190930_lab.xml EX-101.LAB 313070
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arav-20190930_pre.xml EX-101.PRE 224852
Mailing Address LYONDELLBASELL TOWER 1221 MCKINNEY STREET, SUITE 3200 HOUSTON TX 77010
Business Address LYONDELLBASELL TOWER 1221 MCKINNEY STREET, SUITE 3200 HOUSTON TX 77010 936-355-1910
Aravive, Inc. (Filer) CIK: 0001513818 (see all company filings)

IRS No.: 264106690 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36361 | Film No.: 191200779
SIC: 2834 Pharmaceutical Preparations